Contract A207_PO-0440701-V3

The University of Virginia has awarded contract A207_PO-0440701-V3 to Eurofins Genomics LLC, effective August 8, 2026, with a cumulative value of $37.00. The prime contractor will deliver six units each of specialized genomic reagents consisting of six distinct sgGTPBP2 single guide RNA constructs for CRISPR gene editing applications. The line items include three forward (F) strand sequences and three reverse (R) strand sequences, all provided in 50-nucleotide, salt-free formulations: sgGTPBP2 F sg4, sgGTPBP2 R sg4, sgGTPBP2 F sg5, sgGTPBP2 R sg5, sgGTPBP2 F sg6, and sgGTPBP2 R sg6, each priced at $1.00 per unit.

All materials will be delivered to the University of Virginia as the buyer in Virginia. These single guide RNA products are research-grade molecular biology reagents designed to support genomic research and experimentation by directing CRISPR-associated nuclease enzymes to specific DNA target sequences. The contract represents a routine procurement of specialized laboratory supplies for the University's research operations.